Dessislava Stefanova

5PUBLICATIONS
31CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Palliative care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 15, 2023
Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid Carcinoma.

Jessica Limberg, Caitlin E Egan, Katherine D Gray

|Jun 29, 2022
Proposed Risk Stratification and Patterns of Radioactive Iodine Therapy in Malignant Struma Ovarii.

Caitlin Egan, Dessislava Stefanova, Jessica W Thiesmeyer

|Jun 03, 2021
CSPG4 Is a Potential Therapeutic Target in Anaplastic Thyroid Cancer.

Caitlin E Egan, Dessislava Stefanova, Adnan Ahmed

|Aug 02, 2020
Risk Factors for Prolonged Length of Stay and Readmission After Parathyroidectomy for Renal Secondary Hyperparathyroidism.

Dessislava Stefanova, Timothy M Ullmann, Jessica Limberg

Pageof 1